期刊文献+

头孢吡普的合成进展

Progress on the Synthesis of Ceftobiprole
下载PDF
导出
摘要 头孢吡普为广谱头孢菌素类抗生素,其抗菌谱包括耐甲氧西林金葡菌(MRSA)和耐万古霉素金葡球菌(VR-SA)等,应用前景广阔,属于"第五代"头孢菌素类抗生素。介绍了其合成方法。 Ceftobiprole is a broad spectrum cephalosporine antibiotic with activity against methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant Staphylococcus aureus (VRSA), and has an extremely extensive application prospect in the market, so it has been considered as a mumber of the fifth-generation cephalosporine antibiotic.To introduce its synthetic routes.
出处 《河北化工》 2012年第4期17-19,共3页 Hebei Chemical Industry
基金 河北科技大学大学生科技立项活动资助
关键词 头孢菌素 头孢吡普 合成路线 cephalosporine ceftobiprole synthetic route
  • 相关文献

参考文献9

  • 1崔玉彬,蒋晓磊,曹胜华.在研广谱头孢菌素类抗生素的新进展[J].中国抗生素杂志,2010,35(12):881-891. 被引量:7
  • 2张春英,胡海峰.新型抗耐甲氧西林金葡菌抗生素研究进展[J].世界临床药物,2011,32(9):548-551. 被引量:3
  • 3Hebeisen P,Hilpert H,Humm R. New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives[P].WO:2001,'90111,2001.
  • 4Wagraan A S,Moser H E. Carbacepaem beta-lactam antibiotics[P].WO:2010/030810,2010.
  • 5Rogers-Evans M. Preparation of N-protected-3-pyrrolidine-lactam substituted phosphonium salts[P].WO:2002/014332,2002.
  • 6汪洪湖.一种制备头孢呋辛酸的方法[P],CN:102093390,2011.
  • 7Angehm P,Hebeisen P,Heinze-krauss I. Vivyl Pyrrolidine cephalosporins[P].US:5981519,1999.
  • 8Paul S,Georg T. Process for producing cephalosporin derivatives[P].US:6384214,2002.
  • 9Ghetti P,Hebeisen P,Heubes M. New crystal polymorphs of ceftobi-prole[P].WO:2010/072672,2010.

二级参考文献90

  • 1蔡芸,王睿.新型头孢菌素类抗生素ceftobiprole[J].中国新药杂志,2006,15(17):1504-1507. 被引量:4
  • 2傅德才,狄蕊,李彬.头孢菌素类抗生素的研究进展[J].河北师范大学学报(自然科学版),2006,30(6):693-697. 被引量:17
  • 3张致平.近年抗感染药物研究进展.中国抗生素杂志,2009,34:6-39.
  • 4Anderson S D,Gums J G.Ceftobiprole:an extendedspectrum anti-methicillin resistant Staphylococcus aureus cephalosporin[J].Ann Pharmacother,2008,42(6):806-816.
  • 5All A E S.Ceftobiprole:a new broad spectrum cephalosporin[J].Expert Opin Pharmacother,2009,10(10):1675-1686.
  • 6Jones M E.In-vitro profile of a new β-lactam,ceftobiprole,with activity against methicillin resistant Staphylococcus aureus[J].Clin Microbiol Infect,2007,13(S2):17-24.
  • 7Adis International Limited.Ceftobiprole medocaril:BAL5788,JNJ 30982081,JNJ30982081,RO 65-5788,RO 655788[J].Drugs R D,2006,7(5):305-311.
  • 8Bush K,Heep M,Macielag M J,et al.Anti-MRSA β-lactams in development,with a focus on eeftobiprole:the first antiMRSA β-lactam to demonstrate clinical efficacy[J].Expert Opin Investig Drugs,2007,16(4):419-429.
  • 9Neuner E A,Ritehie D J,Micek S T,et al.New antibiotics for healthcare-associated pneumonia[J].Semin Respir Crit Care Med,2009,30(1):92-101.
  • 10Forest Laboratories,Inc.Forest Laboratories presents analysis of two positive pivotal Phase Ⅲ studies of ceftaroline for the treatment of community-acquired pneumonia (CAP) at ICAAC[EB/OL].(2009-09-12)[2009-10-09]http://www.frx.com/news/PressRelease.aspx?ID=1331097.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部